WC
PRVL

Wexford Capital’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Wexford Capital’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,963
Closed -$437K – 408
2020
Q4 		$437K Sell
18,963
-19,000
-50% -$438K 0.07% 133
2020
Q3 		$386K Buy
+37,963
New +$386K 0.1% 96